FastPack TSH Calibrator Kit, REF: 25000024, For use in conjunction with the FastPack IP TSH Immun...

FDA Device Recall #Z-0022-2025 — Class II — August 26, 2024

Recall Summary

Recall Number Z-0022-2025
Classification Class II — Moderate risk
Date Initiated August 26, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Qualigen Inc
Location Carlsbad, CA
Product Type Devices
Quantity 60

Product Description

FastPack TSH Calibrator Kit, REF: 25000024, For use in conjunction with the FastPack IP TSH Immunoassay and FastPack IP System Analyzer

Reason for Recall

Thyroid Stimulating Hormone (TSH) calibrator card has an incorrect barcode linked to incorrect information, that may allow successful system calibration, but the TSH results obtained could be higher than expected.

Distribution Pattern

US: TX, MS, NY, OH, MT, WA, PA, MN, SC, GA, NC, NV, WY, AK, SD, KS, NE, VT, AL, MA, OK, UT, WI, IA, WV. OUS: Germany, Switzerland

Lot / Code Information

UDI-DI: 00816467020099, Lot: 2405017-1, Expiration: 2025-05-15

Other Recalls from Qualigen Inc

Recall # Classification Product Date
Z-0805-2025 Class III The FastPack IP Sex Hormone Binding Globulin Im... Dec 3, 2024
Z-1672-2020 Class II The FastPack System Comlete Immunoassay Kit ... Nov 6, 2019
Z-3112-2017 Class II Qualigen(R) The FastPack(R) IP Vitamin D Comple... Jul 7, 2017
Z-0550-2014 Class II FastPack Free T4 Immunoassay FastPack Vitamin... Nov 8, 2013
Z-0548-2014 Class II FastPack Testosterone Immunoassay Chemilunesc... Nov 8, 2013

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.